INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Liberator Medical Holdings, Inc. of Commencement of a Class Action Challenging the Fairness of the Sale of the Company to C. R. Bard, Inc. -- LBMH

NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) stock prior to November 20, 2015.

You are hereby notified that a class action has been has commenced in Nevada state court challenging the fairness of the sale of Liberator Medical Holdings, Inc. to C. R. Bard, Inc. BCR for $3.35 in cash per share. The claims stem from concerns that the Board of Liberator Medical may have breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and that C. R. Bard, Inc. may be underpaying for Liberator Medical shares. In particular, at least one analyst set a price target of $8.00 per Liberator Medical share. To learn more about the investigation and your rights, go to:

http://zlk.9nl.com/liberator-medical-lbmh

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.